Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation

by Katz, Matthew H., Varadhachary, Gauri R., Fleming, Jason B., Wolff, Robert A., Lee, Jeffrey E., Pisters, Peter W., Vauthey, Jean-Nicolas, Abdalla, Eddie K., Sun, Charlotte C., Wang, Huamin, Crane, Christopher H., Lee, Jeffrey H., Tamm, Eric P., Abbruzzese, James L., Evans, Douglas B.
Published 2010

Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma

by Katz, Matthew H., Wang, Huamin, Fleming, Jason B., Sun, Charlotte C., Hwang, Rosa F., Wolff, Robert A., Varadhachary, Gauri, Abbruzzese, James L., Crane, Christopher H., Krishnan, Sunil, Vauthey, Jean-Nicolas, Abdalla, Eddie K., Lee, Jeffrey E., Pisters, Peter W., Evans, Douglas B.
Published 2009

Glutamine supports pancreatic cancer growth through a Kras-regulated metabolic pathway

by Son, Jaekyoung, Lyssiotis, Costas A., Ying, Haoqiang, Wang, Xiaoxu, Hua, Sujun, Ligorio, Matteo, Perera, Rushika M., Ferrone, Cristina R., Mullarky, Edouard, Shyh-Chang, Ng, Kang, Ya’an, Fleming, Jason B., Bardeesy, Nabeel, Asara, John M., Haigis, Marcia C., DePinho, Ronald A., Cantley, Lewis C., Kimmelman, Alec C.
Published 2014